Cargando…

Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study

Biochemical or clinical changes of hyperandrogenism are important elements of polycystic ovary syndrome (PCOS). There is currently no consensus on the definition and diagnostic criteria of hyperandrogenism in PCOS. The aim of this study was to investigate the complex symptoms of hyperandrogenic diso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Chun, Liu, Xiaoqiang, Mao, Yundong, Diao, Feiyang, Cui, Yugui, Liu, Jiayin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Department of Journal of Biomedical Research 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885167/ https://www.ncbi.nlm.nih.gov/pubmed/27526961 http://dx.doi.org/10.7555/JBR.30.20140111

Ejemplares similares

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
por: Boqun, Xu, et al.
Publicado: (2013)

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels
por: Li, Andi, et al.
Publicado: (2018)

Effects of Upregulation of Hsp27 Expression on Oocyte Development and Maturation Derived from Polycystic Ovary Syndrome
por: Cai, Lingbo, et al.
Publicado: (2013)

Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
por: Zhang, Bingjie, et al.
Publicado: (2018)

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020)

Androgen Excess Increases Food Intake in a Rat Polycystic Ovary Syndrome Model by Downregulating Hypothalamus Insulin and Leptin Signaling Pathways Preceding Weight Gain
por: Liu, Ying, et al.
Publicado: (2022)

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
por: Sanchez-Garrido, Miguel A., et al.
Publicado: (2020)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

Efficacy of dehydroepiandrosterone priming in women with poor ovarian response undergoing IVF/ICSI: a meta-analysis
por: Zhang, Jie, et al.
Publicado: (2023)

Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
por: Kępczyńska-Nyk, A., et al.
Publicado: (2020)

Androgen Excess Induced Mitochondrial Abnormality in Ovarian Granulosa Cells in a Rat Model of Polycystic Ovary Syndrome
por: Song, Linyi, et al.
Publicado: (2022)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

The interplay between androgens and the immune response in polycystic ovary syndrome
por: Shabbir, Sania, et al.
Publicado: (2023)

Comparison of the Association of Excess Weight on Health Related Quality of Life of Women with Polycystic Ovary Syndrome: An Age- and BMI-Matched Case Control Study
por: Shishehgar, Farnaz, et al.
Publicado: (2016)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

High androgen concentrations in follicular fluid of polycystic ovary syndrome women
por: Bongrani, Alice, et al.
Publicado: (2022)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

Follicular output rate tends to improve clinical pregnancy outcomes in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer treatment
por: Tan, Xiaoqing, et al.
Publicado: (2019)

Increased homocysteine regulated by androgen activates autophagy by suppressing the mammalian target of rapamycin pathway in the granulosa cells of polycystic ovary syndrome mice
por: Li, Ting, et al.
Publicado: (2022)

Parents' Readiness to Change Affects BMI Reduction Outcomes in Adolescents with Polycystic Ovary Syndrome
por: Jakubowski, Karen P., et al.
Publicado: (2012)

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2016)

The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome
por: Mesinovic, Jakub, et al.
Publicado: (2020)

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

BMI-Associated Alleles Do Not Constitute Risk Alleles for Polycystic Ovary Syndrome Independently of BMI: A Case-Control Study
por: Louwers, Yvonne V., et al.
Publicado: (2014)

Tpeak-Tend, Tpeak-Tend dispersion and Tpeak-Tend/QT in children and its relationship with clinical variables
por: Castro-Torres, Yaniel, et al.
Publicado: (2019)

Androgens Tend to Be Higher, but What about Altered Progesterone Metabolites in Boys and Girls with Autism?
por: Gasser, Benedikt, et al.
Publicado: (2022)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Salivary and serum androgens with anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2018)

Androgen receptor gene mutations in 258 Han Chinese patients with polycystic ovary syndrome
por: Tian, Lifeng, et al.
Publicado: (2021)

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
por: Ding, Haigang, et al.
Publicado: (2021)

Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome
por: Mansour, Asieh, et al.
Publicado: (2022)

SAT381 Effect of Obesity on Androgen-induced Splenic Dysregulation in Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2023)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

The remedial effect of soluble interleukin-1 receptor type II on endometriosis in the nude mouse model()
por: Gao, Liying, et al.
Publicado: (2010)

Activin A Stimulates Aromatase via the ALK4-Smad Pathway in Endometriosis
por: Zheng, Juan, et al.
Publicado: (2016)

SET protein up-regulated testosterone production in the cultured preantral follicles
por: Xu, Boqun, et al.
Publicado: (2013)

Evaluation of Bone Mineral Density in Children Conceived via Assisted Reproductive Technology
por: Xia, Xinru, et al.
Publicado: (2022)

Effects of Electroacupuncture on Ovarian Expression of the Androgen Receptor and Connexin 43 in Rats with Letrozole-Induced Polycystic Ovaries
por: Xu, Ge, et al.
Publicado: (2020)

Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome
por: Li, Youran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ouedms4h8o9cc6agchmk5ra8hh